Feedback
The current prices are delayed. Login to see live prices.

Caplin Point Laboratories Ltd.

(CAPLIPOINT)

10123456789,901234567899012345678990123456789.8012345678900123456789
-10.30 (-0.51%)
Updated 15:49 28/03 IST
Add
Previous Close: 2010.1
Today's low
₹1,984.65
Today's high
₹2,040.05
52 week low
₹1,225
52 week high
₹2,641
Open
₹2,039
Prev Close
₹2,010.1
Volume (shares)
65,258
Total Trading Value
13.12 Cr

Technicals

SMA
Value
Signal
12-SMA
1,975.57
Bullish
20-SMA
2,033.61
Bearish
50-SMA
2,201.02
Bearish
100-SMA
2,137.05
Bearish
200-SMA
1,873.56
Bullish

Discussions

  •  Mar 18 1:03 PM
Fundamental Analysis of Caplin Point Laboratories Ltd...read more

7

4
  •  Feb 17 3:56 PM
Holding Period: Intraday
Stock: #CAPLIPOINT

17

3
5
  •  Jan 6 4:37 AM
SWING SETUP
Action construction equipment ...read more

1

3

2

  •  Dec 2, 2024 2:06 AM
TIME FRAME - Daily...read more

5

  •  Dec 29, 2024 1:03 AM
Daily chart.....read more

1

1
3
  •  Dec 4, 2024 2:19 PM
Caplin Point Laboratories Ltd view for Intraday 4th Dec #CAPLIPOINT
Resistance 2340. Watching above 2345 for upside movement......read more

1

Load More Posts

Frequently Asked Questions (FAQs)

What is the Share Price of Caplin Point Laboratories Ltd. ?

The share prices are volatile and fluctuate throughout the trading hours. The share price of Caplin Point Laboratories Ltd. is Rs 2010.1 as of 28 March 2025.

What is the Market Capitalization of Caplin Point Laboratories Ltd. ?

The current market cap of Caplin Point Laboratories Ltd. is undefined Market capitalisation is calculated by multiplying the current share price with the total number of shares.

What are the PE and PB ratios of Caplin Point Laboratories Ltd.?

Caplin Point Laboratories Ltd. has a price-to-earnings (PE) ratio of undefined and a price-to-book (PB) ratio of undefined.

What is the 52-week high/low of Caplin Point Laboratories Ltd.?

The 52-week high of Caplin Point Laboratories Ltd. is Rs 2641 and the 52-week low is Rs 1225
Hero Img
Join 10,00,000 Indian traders and discuss trades, strategies, news & views on any stock.
Create your account on Frontpage
DisclaimerPrivacy
FrontPage © 2025